id=228439168 The fusion biopsy market is highly consolidated, with top companies holding significant market shares. The top ...

The global fusion biopsy market is projected to grow at a compound annual growth rate (CAGR) of 7.1%, increasing from an ...

GE Aerospace hiked its dividend 250% in April; GE HealthCare raised its 17% in November; and GE Vernova just initiated a ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pharming Group (PHAR – Research Report) and GE ...

Key industrial partners such as Novo Nordisk, GE Healthcare, petanux, ki:elements and the Centre Hospitalier de Luxembourg play also a leading role. Extended research stays with industrial partners ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

The company split into three standalone public companies: GE Aerospace, GE Vernova, and GE HealthCare in early 2024. GE Aerospace designs and manufactures defense and commercial aircraft engines, ...

Advanced sensor technology in medical devices enhances healthcare delivery, enabling precise diagnostics, continuous ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...

GE HealthCare will take on full ownership of the drug company Nihon Medi-Physics in a transaction with Sumitomo Chemical that is expected to close in early 2025, the company announced Monday.